Publication | Closed Access

Reduced malignant glioblastoma recurrence post-resection through the anti-CD47 antibody and Temozolomide co-embedded in-situ hydrogel system

Neuro-oncologySurgical OncologyGliomaAnti-cd47 AntibodyMedicinePolymer-drug ConjugateTumor TargetingCell BiologyBiomedical EngineeringHigh-grade GliomasMatrix BiologyOncologyRadiation OncologyCancer TreatmentTumor Microenvironment